Market Estimates
Valuation Metrics
Financials
Trading Trends
ENLV News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Enlivex Therapeutics Ltd (ENLV) stock price today?
The current price of ENLV is 0.9017 USD — it has increased 7.64 % in the last trading day.
What is Enlivex Therapeutics Ltd (ENLV)'s business?
Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
What is the price predicton of ENLV Stock?
Wall Street analysts forecast ENLV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENLV is 7.00 USD with a low forecast of 7.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Enlivex Therapeutics Ltd (ENLV)'s revenue for the last quarter?
Enlivex Therapeutics Ltd revenue for the last quarter amounts to 0.00 USD, decreased % YoY.
What is Enlivex Therapeutics Ltd (ENLV)'s earnings per share (EPS) for the last quarter?
Enlivex Therapeutics Ltd. EPS for the last quarter amounts to -0.09 USD, decreased -25.00 % YoY.
What changes have occurred in the market's expectations for Enlivex Therapeutics Ltd (ENLV)'s fundamentals?
How many employees does Enlivex Therapeutics Ltd (ENLV). have?
Enlivex Therapeutics Ltd (ENLV) has 36 emplpoyees as of January 10 2026.
What is Enlivex Therapeutics Ltd (ENLV) market cap?
Today ENLV has the market capitalization of 214.05M USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251126210416_66937f6a191af83c5b59f948259ba166.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fdefault_image%2Ftipranks.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F5e9403ea20a229af7236367088683e6061d53d2843be3945f077b06ef8768ce1.png&w=384&q=75)